About the AACR - Leading Discoveries Magazine

Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 58,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 142 countries and territories around the world. Presently, 32% of members live outside the United States and 22% of AACR’s international members are located in countries with emerging economies. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting. The AACR publishes 10 prestigious, peer-reviewed scientific journals. Other AACR publications include Cancer Today, a magazine for cancer patients and caregivers; the annual AACR Cancer Progress Report; AACR Cancer Disparities Progress Report; AACR Annual Impact Report; Leading Discoveries, the AACR’s awareness and donor magazine; and the blog, Cancer Research Catalyst. In addition, the AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit AACR.org.

AACR Officers

PRESIDENT
Patricia M. LoRusso, DO, PhD (hc), FAACR (2023-2024)
Associate Center Director of Experimental Therapeutics, Director, Early Therapeutics Disease‐Aligned Research Teams, Yale Cancer Center, Professor of Medicine, Yale University, Hamden, Connecticut

PRESIDENT-ELECT
Lillian L. Siu, MD, FAACR (2024-2025)
Professor, University of Toronto, Medical Oncologist, Princess Margaret Cancer Centre, Director, Phase I Program, BMO Financial Group Chair in Precision Genomics, Princess Margaret Cancer Centre, Toronto, Ontario

IMMEDIATE PAST PRESIDENT
Philip D. Greenberg, MD, FAACR (2024-2025)
The Rona Jaffe Foundation Endowed Chair, Professor & Head, Program in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

TREASURER
William N. Hait, MD, PhD, FAACR (2022-2025)
Executive Vice President, Chief External Innovation, Medical Safety, and Global Public Health Officer, Johnson & Johnson, New Brunswick, New Jersey

TREASURER-ELECT
Michael A. Caligiuri, MD, FAACR (2022-2025)
Immediate Past President and Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California

CHIEF EXECUTIVE OFFICER
Margaret Foti, PhD, MD (hc)
American Association for Cancer Research, Philadelphia, Pennsylvania

AACR Directors

John M. Carethers, MD (2023-2026)
Vice Chancellor for Health Sciences, Professor of Medicine, University of California, San Diego,
La Jolla, California

John D. Carpten, PhD, FAACR (2022-2025)
Chief Scientific Officer, Director’s Distinguished Chair, Irell and Manella Cancer Center, Morgan and Helen Chu Director’s Chair, Beckman Research Institute, Director, Comprehensive Cancer Center, Director, Beckman Research Institute, City of Hope, Duarte, California

Christina Curtis, PhD, MSc (2022-2025)
Director, Breast Cancer Translational Research, Co-Director, Molecular Tumor Board, Stanford Cancer Institute, Associate Professor of Medicine and Genetics, Stanford University School of Medicine, Stanford, California

Manuel Hidalgo, MD, PhD (2024-2027)
Professor of Medicine, Walter B. Wriston Professor of Pancreatic Cancer Research, Harvard Medical School, Chief, Division of Hematology and Medical Oncology, Joan and Sanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York

Christine M. Lovly, MD, PhD (2023-2026)
Associate Professor of Medicine, Division of Hematology and Oncology, Ingram Professor of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

William Pao, MD, PhD (2022-2025)
Chief Executive Officer, Revelio Therapeutics, New York, New York

Electra D. Paskett, PhD (2024-2027)
Marion N. Rowley Professor of Cancer Research and Director, Division of Cancer Prevention and Control, Department of Internal Medicine, Distinguished Professor, College of Medicine, Professor, Division of Epidemiology, College of Public Health, Deputy Director for Population Sciences and Community Outreach Comprehensive Cancer Center, Founding Director, Center for Cancer Health Equity, James Cancer Hospital, The Ohio State University, Columbus, Ohio

Elizabeth A. Platz, ScD, MPH (2023-2026)
Professor and Martin D. Abeloff, MD, Scholar in Cancer Prevention, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

Katerina A. Politi, PhD (2024-2027)
Professor of Pathology, Co-Leader, Cancer Signaling Networks, Scientific Director, Center for Thoracic Cancers, Yale Cancer Center, New Haven, Connecticut

Alice T. Shaw, MD, PhD (2023-2026)
Chief of Strategic Partnerships, Dana-Farber Cancer Institute, Boston, Massachusetts

Jean-Charles Soria, MD, PhD (2024-2027)
Senior Vice President of Oncology, Global Development, Amgen, Thousand Oaks, California

Kimberly Stegmaier, MD (2022-2025)
Professor, Pediatrics, Harvard Medical School, Principal Investigator, Pediatric Oncology, Dana-Farber Cancer Institute, Co-Director, Pediatric Hematologic Malignancy Program, Boston Children’s Hospital and Dana-Farber Cancer Institute, Ted Williams Chair, Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Robert H. Vonderheide, MD, DPhil (2022-2025)
Director, Abramson Cancer Center, John H. Glick Abramson Cancer Center Professor, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania

Jedd D. Wolchok, MD, PhD, FAACR (2023-2026)
Director, Sandra and Edward Meyer Cancer Center, Professor of Medicine, Weill Cornell Medicine,
New York, New York

Catherine J. Wu, MD, FAACR (2024-2027)
Professor of Medicine, Chief, Division of Stem Cell Transplantation and Cellular Therapies, Lavine Family Chair for Preventative Cancer Therapies, Dana-Farber Cancer Institute, Boston Massachusetts